NCT01484808Unknown不适用
Retrospective Review of Reduce Data to Determine the Utility of PSADv While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
University Urological Associates Inc.1 个研究点 分布在 1 个国家目标入组 6,600 人开始时间: 2012年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 6,600
- 试验地点
- 1
研究概览
简要总结
This is a review of previously published data from a large prostate cancer prevention study known as REDUCE. It is the investigators intention to review whether prostate specific antigen (PSA) velocity (change over time) will predict the presence of prostate cancer and its grade and stage (severity).
详细描述
This is a review of previously published data from a large prostate cancer prevention study known as REDUCE that utilized a 5 ARI, dutasteride. It is the investigators intention to review whether PSA velocity (change over time) will predict the presence of prostate cancer and its grade and stage (severity) by two year biopsy. The investigator will review and compare data to a previously published study of similar design with finasteride.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 50 Years 至 74 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •50-74 years old with elevated PSA (>=4) along with negative entry biopsy of the prostate who had a subsequent biopsy by 24 months.
排除标准
- •Any positive biopsy of the prostate indicative of cancer upon entry
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant StateProstate CancerNCT01560858Ipsen407
已完成
不适用
For Cause Prostate Biopsy in REDUCE Population TrialProstate CancerNCT01529086The Cleveland Clinic6,608
进行中（未招募）
不适用
Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective StudyProstate CancerNCT06347614Sun Yat-sen University30
已完成
不适用
A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in ItalyProstate CancerNCT05759273Ipsen167
招募中
不适用
The Active Surveillance StudyProstate CancerNCT05810467Institute of Cancer Research, United Kingdom200